Dare Bioscience Competitors and Similar CompaniesClear all

Greenwich LifeSciences's competitors and similar companies include Nanospectra Biosciences, CNS Pharmaceuticals and NexImmune.

	Greenwich LifeSciences Greenwich LifeSciences is a clinical-stage biopharmaceutical company.	Nanospectra Biosciences Nanospectra Biosciences is a company specializing in nanomedicine for selective thermal ablation.	CNS Pharmaceuticals CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in the development of treatments for brain tumors.	NexImmune NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform.
Founding Date	Founding Date 2006	Founding Date 2002	Founding Date 2017	Founding Date 2011
Type	Type Public	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech life sciences oncology pharma therapy	Tags Healthcare medical devices medtech nanotech oncology therapy	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development nanotech oncology pharma
Locations	Locations Stafford, US HQ	Locations Houston, US HQ	Locations Houston, US HQ	Locations Gaithersburg, US HQ
Employees	Employees 433% increase	Employees 6	Employees 433% increase	Employees 5032% decrease
Valuation ($)	Valuation ($) 186 m	Valuation ($) N/A	Valuation ($) 4.7 m	Valuation ($) 372.4 k
Financial
Net income	Net income ($15.8m) (FY, 2024)	Net income N/A	Net income ($15.9m) (FY, 2025)	Net income ($32.3m) (FY, 2023)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 4.3m	Total funding raised N/A	Total funding raised $ 33.8m